Multifocal motor neuropathy: Diagnosis, pathogenesis and treatment strategies

Nature Reviews Neurology

Volumn 8, Issue 1, 2012, Pages 48-58

  Vlam, Lotte ^a   Van Der Pol, W Ludo ^a   Cats, Elisabeth A ^a   Straver, Dirk C ^a   Piepers, Sanneke ^a   Franssen, Hessel ^a   Van Den Berg, Leonard H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BETA INTERFERON; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ECULIZUMAB; IMMUNOGLOBULIN; IMMUNOGLOBULIN M ANTIBODY; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO; RITUXIMAB;

AMYOTROPHIC LATERAL SCLEROSIS; ANTIBODY TITER; ARTHRALGIA; AUTOIMMUNITY; BORDERLINE HYPERTENSION; BRAIN ELECTROPHYSIOLOGY; CHILL; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; FEVER; GM1 GANGLIOSIDOSIS; HEADACHE; HUMAN; HYPOTENSION; IMMUNOPATHOLOGY; MALAISE; MOTOR NEURON DISEASE; MOTOR NEUROPATHY; MULTIFOCAL MOTOR NEUROPATHY; NAUSEA; NERVE BLOCK; NERVE FIBER DEGENERATION; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; RASH; REVIEW; SENSORY NERVE CONDUCTION;

HUMANS; MOTOR NEURON DISEASE; POLYNEUROPATHIES;

EID: 84655167153     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2011.175     Document Type: Review

References (140)

1. Cats, E. A. et al. Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy. Neurology 75, 818-825 (2010).
2. Chad, D. A., Hammer, K. & Sargent, J. Slow resolution of multifocal weakness and fasciculation: A reversible motor neuron syndrome. Neurology 36, 1260-1263 (1986). (Pubitemid 16047012)
3. Roth, G., Rohr, J., Magistris, M. R. & Ochsner, F. Motor neuropathy with proximal multifocal persistent conduction block, fasciculations and myokymia. Evolution to tetraplegia. Eur. Neurol. 25, 416-423 (1986). (Pubitemid 17179395)
4. Parry, G. J. & Clarke, S. Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease. Muscle Nerve 11, 103-107 (1988). (Pubitemid 18039607)
5. Pestronk, A. et al. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann. Neurol. 24, 73-78 (1988).
6. Pestronk, A. et al. Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies. Ann. Neurol. 27, 316-326 (1990). (Pubitemid 20122384)
7. Lange, D. J. et al. Multifocal motor neuropathy with conduction block: Is it a distinct clinical entity? Neurology 42, 497-505 (1992).
8. Bouche, P. et al. Multifocal motor neuropathy with conduction block: A study of 24 patients. J. Neurol. Neurosurg. Psychiatry. 59, 38-44 (1995).
9. Jaspert, A., Claus, D., Grehl, H. & Neundorfer, B. Multifocal motor neuropathy: Clinical and electrophysiological findings. J. Neurol. 243, 684-692 (1996). (Pubitemid 26371924)
10. Le Forestier, N. et al. Multifocal motor neuropathies with conduction blocks. 39 cases. Rev. Neurol. (Paris) 153, 579-586 (1997). (Pubitemid 27488134)
11. Bentes, C., de Carvalho, M., Evangelista, T. & Sales-Luis, M. L. Multifocal motor neuropathy mimicking motor neuron disease: Nine cases. J. Neurol. Sci. 169, 76-79 (1999). (Pubitemid 29502510)
12. Taylor, B. V., Wright, R. A., Harper, C. M. & Dyck, P. J. Natural history of 46 patients with multifocal motor neuropathy with conduction block. Muscle Nerve 23, 900-908 (2000). (Pubitemid 30354497)
13. Azulay, J. P. et al. Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: A double-blind, placebo-controlled study. Neurology 44, 429-432 (1994).
14. Van den Berg, L. H. et al. Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: A double blind, placebo controlled study. J. Neurol. Neurosurg. Psychiatry 59, 248-252 (1995).
15. Federico, P., Zochodne, D. W., Hahn, A. F., Brown, W. F. & Feasby, T. E. Multifocal motor neuropathy improved by IVIg: Randomized, double-blind, placebo-controlled study. Neurology 55, 1256-1262 (2000).
16. Leger, J. M. et al. Intravenous immunoglobulin therapy in multifocal motor neuropathy: A double-blind, placebo-controlled study. Brain 124, 145-153 (2001).
17. Van den Berg-Vos, R. M., Franssen, H., Wokke, J. H. & Van den Berg, L. H. Multifocal motor neuropathy: Long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment. Brain 125, 1875-1886 (2002).
18. Terenghi, F. et al. How long is IVIg effective in multifocal motor neuropathy? Neurology 62, 666-668 (2004). (Pubitemid 38252820)
19. Nobile-Orazio, E. Multifocal motor neuropathy. J. Neuroimmunol. 115, 4-18 (2001). (Pubitemid 32245648)
20. Slee, M., Selvan, A. & Donaghy, M. Multifocal motor neuropathy: The diagnostic spectrum and response to treatment. Neurology 69, 1680-1687 (2007). (Pubitemid 350287124)
21. Van Asseldonk, J. T. et al. Demyelination and axonal loss in multifocal motor neuropathy: Distribution and relation to weakness. Brain 126, 186-198 (2003). (Pubitemid 36068569)
22. Van den Berg-Vos, R. M. et al. Disease severity in multifocal motor neuropathy and its association with the response to immunoglobulin treatment. J. Neurol. 249, 330-336 (2002).
23. Straver, D. C. et al. Cold paresis in multifocal motor neuropathy. J. Neurol. 258, 212-217 (2011).
24. O'Leary, C. P., Mann, A. C., Lough, J. & Willison, H. J. Muscle hypertrophy in multifocal motor neuropathy is associated with continuous motor unit activity. Muscle Nerve 20, 479-485 (1997). (Pubitemid 27154639)
25. Delmont, E. et al. Do patients having a decrease in SNAP amplitude during the course of MMN present with a different condition? J. Neurol. 256, 1876-1880 (2009).
26. Lambrecq, V., Krim, E., Rouanet-Larriviere, M. & Lagueny, A. Sensory loss in multifocal motor neuropathy: A clinical and electrophysiological study. Muscle Nerve 39, 131-136 (2009).
27. Lievens, I. et al. Multifocal motor neuropathy: A retrospective study of sensory nerve conduction velocities in long-term follow-up of 21 patients. Rev. Neurol. (Paris) 165, 243-248 (2009).
28. Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of multifocal motor neuropathy: Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society-first revision. J. Peripher. Nerv. Syst. 15, 295-301 (2010).
29. Pringle, C. E., Belden, J., Veitch, J. E. & Brown, W. F. Multifocal motor neuropathy presenting as ophthalmoplegia. Muscle Nerve 20, 347-351 (1997). (Pubitemid 27108154)
30. Kaji, R., Shibasaki, H. & Kimura, J. Multifocal demyelinating motor neuropathy: Cranial nerve involvement and immunoglobulin therapy. Neurology 42, 506-509 (1992).
31. Kyriakides, T., Papacostas, S., Papanicolaou, E., Bagdades, E. & Papathanasiou, E. S. Sleep hypoventilation syndrome and respiratory failure due to multifocal motor neuropathy with conduction block. Muscle Nerve 43, 610-614 (2011).
32. Beydoun, S. R. & Copeland, D. Bilateral phrenic neuropathy as a presenting feature of multifocal motor neuropathy with conduction block. Muscle Nerve 23, 556-559 (2000). (Pubitemid 30164782)
33. Boonyapisit, K. & Katirji, B. Multifocal motor neuropathy presenting with respiratory failure. Muscle Nerve 23, 1887-1890 (2000).
34. Cavaletti, G. et al. Rapidly progressive multifocal motor neuropathy with phrenic nerve paralysis: Effect of nocturnal assisted ventilation. J. Neurol. 245, 613-616 (1998). (Pubitemid 28431897)
35. Van Asseldonk, J. T. et al. Axon loss is an important determinant of weakness in multifocal motor neuropathy. J. Neurol. Neurosurg. Psychiatry 77, 743-747 (2006). (Pubitemid 43837201)
36. van den Berg-Vos, R. M. et al. Sporadic lower motor neuron disease with adult onset: Classification of subtypes. Brain 126, 1036-1047 (2003).
37. Traynor, B. J. et al. Amyotrophic lateral sclerosis mimic syndromes: A population-based study. Arch. Neurol. 57, 109-113 (2000). (Pubitemid 30027638)
38. Donaghy, M. Classification and clinical features of motor neurone diseases and motor neuropathies in adults. J. Neurol. 246, 331-333 (1999). (Pubitemid 29261419)
39. Visser, J. et al. Mimic syndromes in sporadic cases of progressive spinal muscular atrophy. Neurology 58, 1593-1596 (2002). (Pubitemid 34602887)
40. Van Asseldonk, J. T. et al. Demyelination and axonal loss in multifocal motor neuropathy: Distribution and relation to weakness. Brain 126, 186-198 (2003). (Pubitemid 36068569)
41. Van den Berg-Vos, R. M., Franssen, H., Wokke, J. H., Van Es, H. W. & Van den Berg, L. H. Multifocal motor neuropathy: Diagnostic criteria that predict the response to immunoglobulin treatment. Ann. Neurol. 48, 919-926 (2000).
42. Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-First Revision. J. Peripher. Nerv. Syst. 15, 1-9 (2010).
43. Lewis, R. A., Sumner, A. J., Brown, M. J. & Asbury, A. K. Multifocal demyelinating neuropathy with persistent conduction block. Neurology 32, 958-964 (1982). (Pubitemid 12049457)
44. Parry, G. J. Are multifocal motor neuropathy and Lewis-Sumner syndrome distinct nosologic entities? Muscle Nerve 22, 557-559 (1999). (Pubitemid 29214419)
45. Van den Berg-Vos, R. M. et al. Multifocal inflammatory demyelinating neuropathy: A distinct clinical entity? Neurology 54, 26-32 (2000). (Pubitemid 30038733)
46. Oh, S. J., Claussen, G. C. & Kim, D. S. Motor and sensory demyelinating mononeuropathy multiplex (multifocal motor and sensory demyelinating neuropathy): A separate entity or a variant of chronic inflammatory demyelinating polyneuropathy? J. Peripher. Nerv. Syst. 2, 362-369 (1997). (Pubitemid 127687134)
47. Gorson, K. C., Ropper, A. H. & Weinberg, D. H. Upper limb predominant, multifocal chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 22, 758-765 (1999). (Pubitemid 29256845)
48. Lewis, R. A. Multifocal motor neuropathy and Lewis Sumner syndrome: Two distinct entities. Muscle Nerve 22, 1738-1739 (1999).
49. Saperstein, D. S. et al. Multifocal acquired demyelinating sensory and motor neuropathy: The Lewis-Sumner syndrome. Muscle Nerve 22, 560-566 (1999). (Pubitemid 29214420)
50. Saperstein, D. S., Katz, J. S., Amato, A. A. & Barohn, R. J. Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 24, 311-324 (2001). (Pubitemid 32172706)
51. Viala, K. et al. Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome. Brain 127, 2010-2017 (2004). (Pubitemid 39150259)
52. Verschueren, A. et al. Lewis-Sumner syndrome and multifocal motor neuropathy. Muscle Nerve 31, 88-94 (2005). (Pubitemid 40053931)
53. Lewis, R. A. Neuropathies associated with conduction block. Curr. Opin. Neurol. 20, 525-530 (2007). (Pubitemid 47462280)
54. Nobile-Orazio, E., Cappellari, A. & Priori, A. Multifocal motor neuropathy: Current concepts and controversies. Muscle Nerve 31, 663-680 (2005). (Pubitemid 40734675)
55. Beydoun, S. R. Multifocal motor neuropathy with conduction block misdiagnosed as multiple entrapment neuropathies. Muscle Nerve 21, 813-815 (1998). (Pubitemid 28248691)
56. Hughes, P. R. 79th ENMC International Workshop: Multifocal motor neuropathy. 14-15 April 2000, Hilversum, The Netherlands. Neuromuscul. Disord. 11, 309-314 (2001). (Pubitemid 32288803)
57. Olney, R. K., Lewis, R. A., Putnam, T. D., Campellone, J. V. Jr & American Association of Electrodiagnostic Medicine. Consensus criteria for the diagnosis of multifocal motor neuropathy. Muscle Nerve 27, 117-121 (2003). (Pubitemid 36083455)
58. van Schaik, I. N. et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Eur. J. Neurol. 13, 802-808 (2006). (Pubitemid 44124675)
59. Van Asseldonk, J. T., Van den Berg, L. H., Wieneke, G. H., Wokke, J. H. & Franssen, H. Criteria for conduction block based on computer simulation studies of nerve conduction with human data obtained in the forearm segment of the median nerve. Brain 129, 2447-2460 (2006). (Pubitemid 44522129)
60. Van Asseldonk, J. T., Franssen, H., Van den Berg-Vos, R. M., Wokke, J. H. & Van den Berg, L. H. Multifocal motor neuropathy. Lancet Neurol. 4, 309-319 (2005). (Pubitemid 40545042)
61. Delmont, E. et al. Multifocal motor neuropathy with and without conduction block: A single entity? Neurology 67, 592-596 (2006). (Pubitemid 44273604)
62. Chaudhry, V. & Swash, M. Multifocal motor neuropathy: Is conduction block essential? Neurology 67, 558-559 (2006). (Pubitemid 44273596)
63. Menkes, D. L. Multifocal motor neuropathy with and without conduction block: A single entity? Neurology 68, 1161-1162 (2007). (Pubitemid 46559859)
64. Menkes, D. L., Hood, D. C., Ballesteros, R. A. & Williams, D. A. Root stimulation improves the detection of acquired demyelinating polyneuropathies. Muscle Nerve 21, 298-308 (1998). (Pubitemid 28096039)
65. Arunachalam, R., Osei-Lah, A. & Mills, K. R. Transcutaneous cervical root stimulation in the diagnosis of multifocal motor neuropathy with conduction block. J. Neurol. Neurosurg. Psychiatry. 74, 1329-1331 (2003).
66. Attarian, S., Azulay, J. P., Verschueren, A. & Pouget, J. Magnetic stimulation using a triple-stimulation technique in patients with multifocal neuropathy without conduction block. Muscle Nerve 32, 710-714 (2005). (Pubitemid 41748277)
67. Deroide, N. et al. Triple-stimulation technique in multifocal neuropathy with conduction block. Muscle Nerve 35, 632-636 (2007). (Pubitemid 46676852)
68. Kaji, R. et al. Activity-dependent conduction block in multifocal motor neuropathy. Brain 123, 1602-1611 (2000). (Pubitemid 30481184)
69. Nodera, H. et al. Activity-dependent conduction block in multifocal motor neuropathy: Magnetic fatigue test. Neurology 67, 280-287 (2006). (Pubitemid 44305413)
70. Hitomi, T. et al. Dynamic change of proximal conduction in demyelinating neuropathies: A cervical magnetic stimulation combined with maximum voluntary contraction. Clin. Neurophysiol. 118, 741-750 (2007). (Pubitemid 46349818)
71. Straver, D. C., van den Berg, L. H., van den Berg-Vos, R. M. & Franssen, H. Activity-dependent conduction block in multifocal motor neuropathy. Muscle Nerve 43, 31-36 (2011).
72. Parry, G. J. AAEM case report #30: Multifocal motor neuropathy. Muscle Nerve 19, 269-276 (1996).
73. van Schaik, I. N., Bossuyt, P. M., Brand, A. & Vermeulen, M. Diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies: A meta-analysis. Neurology 45, 1570-1577 (1995).
74. Taylor, B. V., Gross, L. & Windebank, A. J. The sensitivity and specificity of anti-GM1 antibody testing. Neurology 47, 951-955 (1996).
75. Cats, E. A. et al. Multifocal motor neuropathy: Association of anti-GM1 IgM antibodies with clinical features. Neurology 75, 1961-1967 (2010).
76. Willison, H. J. & Yuki, N. Peripheral neuropathies and anti-glycolipid antibodies. Brain 125, 2591-2625 (2002). (Pubitemid 35423511)
77. Nobile-Orazio, E. et al. How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies? J. Neurol. Sci. 266, 156-163 (2008). (Pubitemid 351193061)
78. Gooch, C. L. & Amato, A. A. Are anti-ganglioside antibodies of clinical value in multifocal motor neuropathy? Neurology 75, 1950-1951 (2010).
79. Van Es, H. W. et al. Magnetic resonance imaging of the brachial plexus in patients with multifocal motor neuropathy. Neurology 48, 1218-1224 (1997). (Pubitemid 27240537)
80. Echaniz-Laguna, A. & Dietemann, J. L. Seeing the blocks: MRI of the brachial plexus in multifocal motor neuropathy. J. Neurol. Neurosurg. Psychiatry 82, 728 (2011).
81. Beekman, R. et al. Ultrasonography shows extensive nerve enlargements in multifocal motor neuropathy. Neurology 65, 305-307 (2005). (Pubitemid 41022381)
82. Priori, A. et al. Distinctive abnormalities of motor axonal strength-duration properties in multifocal motor neuropathy and in motor neurone disease. Brain 125, 2481-2490 (2002).
83. Kiernan, M. C., Guglielmi, J. M., Kaji, R., Murray, N. M. & Bostock, H. Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block. Brain 125, 664-675 (2002). (Pubitemid 34194419)
84. Kaji, R. Physiology of conduction block in multifocal motor neuropathy and other demyelinating neuropathies. Muscle Nerve 27, 285-296 (2003). (Pubitemid 36255388)
85. Priori, A. et al. Pathophysiological heterogeneity of conduction blocks in multifocal motor neuropathy. Brain 128, 1642-1648 (2005). (Pubitemid 41373683)
86. Auer, R. N., Bell, R. B. & Lee, M. A. Neuropathy with onion bulb formations and pure motor manifestations. Can. J. Neurol. Sci. 16, 194-197 (1989). (Pubitemid 19161247)
87. Kaji, R. et al. Pathological findings at the site of conduction block in multifocal motor neuropathy. Ann. Neurol. 33, 152-158 (1993). (Pubitemid 23039923)
88. Corbo, M. et al. Motor nerve biopsy studies in motor neuropathy and motor neuron disease. Muscle Nerve 20, 15-21 (1997). (Pubitemid 27009464)
89. Taylor, B. V. et al. Multifocal motor neuropathy: Pathologic alterations at the site of conduction block. J. Neuropathol. Exp. Neurol. 63, 129-137 (2004). (Pubitemid 38174778)
90. Vucic, S., Black, K., Chong, P. S. & Cros, D. Multifocal motor neuropathy with conduction block: Distribution of demyelination and axonal degeneration. Clin. Neurophysiol. 118, 124-130 (2007). (Pubitemid 46001771)
91. Vucic, S., Black, K. R., Chong, P. S. & Cros, D. Multifocal motor neuropathy: Decrease in conduction blocks and reinnervation with long-term IVIg. Neurology 63, 1264-1269 (2004). (Pubitemid 39350028)
92. Ogawa-Goto, K., Funamoto, N., Ohta, Y., Abe, T. & Nagashima, K. Myelin gangliosides of human peripheral nervous system: An enrichment of GM1 in the motor nerve myelin isolated from cauda equina. J. Neurochem. 59, 1844-1849 (1992).
93. Susuki, K. et al. Gangliosides contribute to stability of paranodal junctions and ion channel clusters in myelinated nerve fibers. Glia 55, 746-757 (2007). (Pubitemid 46663027)
94. Susuki, K. et al. Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J. Neurosci. 27, 3956-3967 (2007). (Pubitemid 46597169)
95. Arasaki, K., Kusunoki, S., Kudo, N. & Kanazawa, I. Acute conduction block in vitro following exposure to antiganglioside sera. Muscle Nerve 16, 587-593 (1993). (Pubitemid 23157329)
96. Uncini, A., Santoro, M., Corbo, M., Lugaresi, A. & Latov, N. Conduction abnormalities induced by sera of patients with multifocal motor neuropathy and anti-GM1 antibodies. Muscle Nerve 16, 610-615 (1993). (Pubitemid 23157332)
97. Roberts, M., Willison, H. J., Vincent, A. & Newsom-Davis, J. Multifocal motor neuropathy human sera block distal motor nerve conduction in mice. Ann. Neurol. 38, 111-118 (1995).
98. Harvey, G. K. et al. Failure of anti-GM1 IgG or IgM to induce conduction block following intraneural transfer. Muscle Nerve 18, 388-394 (1995).
99. Hirota, N. et al. The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons. Brain 120, 2159-2169 (1997). (Pubitemid 28014592)
100. Yuki, N., Watanabe, H., Nakajima, T. & Spath, P. J. IVIG blocks complement deposition mediated by anti-GM1 antibodies in multifocal motor neuropathy. J. Neurol. Neurosurg. Psychiatry 82, 87-91 (2011).
101. Piepers, S. et al. IVIg inhibits classical pathway activity and anti-GM1 IgM-mediated complement deposition in MMN. J. Neuroimmunol. 229, 256-262 (2010).
102. Jacobs, B. C. et al. Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding. Brain 126, 2220-2234 (2003). (Pubitemid 37432366)
103. Halstead, S. K. et al. Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model. Brain 131, 1197-1208 (2008).
104. Jacobs, B. C. et al. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome. Ann. Neurol. 40, 181-187 (1996).
105. Terenghi, F., Allaria, S., Scarlato, G. & Nobile-Orazio, E. Multifocal motor neuropathy and Campylobacter jejuni reactivity. Neurology 59, 282-284 (2002). (Pubitemid 34779193)
106. Eurelings, M. et al. Antiganglioside antibodies in polyneuropathy associated with monoclonal gammopathy. Neurology 57, 1909-1912 (2001). (Pubitemid 33096708)
107. Kaida, K. et al. Ganglioside complexes as new target antigens in Guillain-Barré syndrome. Ann. Neurol. 56, 567-571 (2004). (Pubitemid 39319349)
108. Nobile-Orazio, E., Giannotta, C. & Briani, C. Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies. J. Neuroimmunol. 219, 119-122 (2010).
109. Pestronk, A., Choksi, R., Blume, G. & Lopate, G. Multifocal motor neuropathy: Serum IgM binding to a GM1 ganglioside-containing lipid mixture but not to GM1 alone. Neurology 48, 1104-1106 (1997).
110. Pestronk, A., Chuquilin, M. & Choksi, R. Motor neuropathies and serum IgM binding to NS6S heparin disaccharide or GM1 ganglioside. J. Neurol. Neurosurg. Psychiatry. 81, 726-730 (2010).
111. van der Pol, W. L., Cats, E. A. & van den Berg, L. H. Intravenous immunoglobulin treatment in multifocal motor neuropathy. J. Clin. Immunol. 30 (Suppl. 1), S79-S83 (2010).
112. Klein, J. & Sato, A. The HLA system: First of two parts. N. Engl. J. Med. 343, 702-709 (2000).
113. Sutedja, N. A. et al. Increased frequency of HLA-DRB1*15 in patients with multifocal motor neuropathy. Neurology 74, 828-832 (2010).
114. Schmidt, H., Williamson, D. & Ashley-Koch, A. HLA-DR15 haplotype and multiple sclerosis: A HuGE review. Am. J. Epidemiol. 165, 1097-1109 (2007). (Pubitemid 47233710)
115. Vlam, L. et al. Multifocal motor neuropathy is not associated with genetic variation in PTPN22, BANK1, Blk, FCGR2B, CD1A/E and TAG-1 genes. J. Peripher. Nerv. Syst. 16, 175-179 (2011).
116. van Schaik, I. N., van den Berg, L. H., de Haan, R. & Vermeulen, M. Intravenous immunoglobulin for multifocal motor neuropathy. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD004429. http://dx.doi.org/10.1002/ 14651858.CD004429.pub2 (2005).
117. Leger, J. M. et al. Intravenous immunoglobulin as short- and long-term therapy of multifocal motor neuropathy: A retrospective study of response to IVIg and of its predictive criteria in 40 patients. J. Neurol. Neurosurg. Psychiatry 79, 93-96 (2008).
118. Baumann, A., Hess, C. W. & Sturzenegger, M. IVIg dose increase in multifocal motor neuropathy: A prospective six month follow-up. J. Neurol. 256, 608-614 (2009).
119. Merkies, I. S. & Schmitz, P. I. Getting closer to patients: The INCAT Overall Disability Sum Score relates better to patients' own clinical judgement in immune-mediated polyneuropathies. J. Neurol. Neurosurg. Psychiatry 77, 970-972 (2006). (Pubitemid 44174088)
120. Leger, J. M. & Salachas, F. Diagnosis of motor neuropathy. Eur. J. Neurol. 8, 201-208 (2001). (Pubitemid 32476616)
121. Cats, E. A., van der Pol, W. L., Bertens, A. S. & van den Berg, L. H. Home-based IVIg treatment is convenient and time-saving in patients with multifocal motor neuropathy. J. Peripher. Nerv. Syst. 16, 147-149 (2011).
122. Eftimov, F., Vermeulen, M., de Haan, R. J., van den Berg, L. H. & van Schaik, I. N. Subcutaneous immunoglobulin therapy for multifocal motor neuropathy. J. Peripher. Nerv. Syst. 14, 93-100 (2009).
123. Harbo, T. et al. Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: A randomized, single-blinded cross-over trial. Eur. J. Neurol. 16, 631-638 (2009).
124. Misbah, S. A. et al. A smooth transition protocol for patients with multifocal motor neuropathy going from intravenous to subcutaneous immunoglobulin therapy: An open-label proof-of-concept study. J. Peripher. Nerv. Syst. 16, 92-97 (2011).
125. Harbo, T., Andersen, H. & Jakobsen, J. Long-term therapy with high doses of subcutaneous immunoglobulin in multifocal motor neuropathy. Neurology 75, 1377-1380 (2010).
126. Van den Berg, L. H., Franssen, H. & Wokke, J. H. The long-term effect of intravenous immunoglobulin treatment in multifocal motor neuropathy. Brain 121, 421-428 (1998). (Pubitemid 28116339)
127. Van den Berg, L. H., Lokhorst, H. & Wokke, J. H. Pulsed high-dose dexamethasone is not effective in patients with multifocal motor neuropathy. Neurology 48, 1135 (1997).
128. Carpo, M. et al. Deterioration of multifocal motor neuropathy after plasma exchange. Neurology 50, 1480-1482 (1998). (Pubitemid 28240378)
129. Lehmann, H. C. et al. The clinical value of therapeutic plasma exchange in multifocal motor neuropathy. J. Neurol. Sci. 271, 34-39 (2008).
130. Eftimov, F. & Van Schaik, I. N. Immunotherapy of multifocal motor neuropathy. Expert Opin. Biol. Ther. 11, 329-342 (2011).
131. Umapathi, T., Hughes, R. A., Nobile-Orazio, E. & Leger, J. M. Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy. Cochrane Database of Systematic Reviews, Issue 1, Art. No.: CD003217. http://dx.doi.org/10.1002/14651858.CD003217.pub3 (2009).
132. Nobile-Orazio, E., Gallia, F., Tuccillo, F. & Terenghi, F. Chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: Treatment update. Curr. Opin. Neurol. 23, 519-523 (2010).
133. Piepers, S. et al. Mycophenolate mofetil as adjunctive therapy for MMN patients: A randomized, controlled trial. Brain 130, 2004-2010 (2007). (Pubitemid 47236626)
134. Fitzpatrick, A. M. et al. An open label clinical trial of complement inhibition in multifocal motor neuropathy. J. Peripher. Nerv. Syst. 16, 84-91 (2011).
135. Pestronk, A. et al. Treatment of IgM antibody associated polyneuropathies using rituximab. J. Neurol. Neurosurg. Psychiatry 74, 485-489 (2003). (Pubitemid 36379372)
136. Rojas-Garcia, R. et al. Chronic neuropathy with IgM anti-ganglioside antibodies: Lack of long term response to rituximab. Neurology 61, 1814-1816 (2003). (Pubitemid 38020840)
137. Ruegg, S. J., Fuhr, P. & Steck, A. J. Rituximab stabilizes multifocal motor neuropathy increasingly less responsive to IVIg. Neurology 63, 2178-2179 (2004). (Pubitemid 39636279)
138. Gorson, K. C., Natarajan, N., Ropper, A. H. & Weinstein, R. Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: A prospective pilot trial. Muscle Nerve 35, 66-69 (2007). (Pubitemid 46052650)
139. Stieglbauer, K., Topakian, R., Hinterberger, G. & Aichner, F. T. Beneficial effect of rituximab monotherapy in multifocal motor neuropathy. Neuromuscul. Disord. 19, 473-475 (2009).
140. Chaudhry, V. & Cornblath, D. R. An open-label trial of rituximab (Rituxan®) in multifocal motor neuropathy. J. Peripher. Nerv. Syst. 15, 196-201 (2010).